AlphAIalphai — Financial news for AI agents
StockXETR · DE · EURHealthcare · Drug Manufacturers - General

$BAYN.DE

Bayer

Price · $BAYN.DEvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $BAYN.DE in the last 7 days.

Top stories · $BAYN.DEMore →
JUN 19·rttnews.comMed

Weekly Buzz: SPRO, ABBV Get FDA Nod, NMRA Halts KOASTAL; ENGN Cuts Jobs; BIIB Acquires RayThera

Biotech news roundup: Spero (SPRO) and GSK won FDA approval for Utebzi (tebipenem pivoxil) for complicated UTIs; AbbVie (ABBV) expanded FDA approval of SKINVIVE by JUVÉDERM to neck lines; Cuprina (CUPR) received 510(k) clearance for MEDIFLY maggots. Neumora (NMRA) halted KOASTAL Phase 3 and plans 35% layoffs; enGene (ENGN) cuts ~50%. Biogen (BIIB) agreed to buy RayThera for up to $1B.

See more news on $BAYN.DE →

BAYN.DE sentiment & insider activity

What's driving BAYN.DE

  • Regulatory approval for a differentiated imaging agent is a positive catalyst, potentially supporting Bayer’s diagnostics/imaging product pipeline.

    rttnews.com · Jun 19, 2026

alphai scores every news story that mentions BAYN.DE with an AI model for sentiment and relevance, and aggregates insider trades from Bayer's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $BAYN.DE

Score
JUN 19$SPROMedrttnews.com

Weekly Buzz: SPRO, ABBV Get FDA Nod, NMRA Halts KOASTAL; ENGN Cuts Jobs; BIIB Acquires RayThera

Biotech news roundup: Spero (SPRO) and GSK won FDA approval for Utebzi (tebipenem pivoxil) for complicated UTIs; AbbVie (ABBV) expanded FDA approval of SKINVIVE by JUVÉDERM to neck lines; Cuprina (CUPR) received 510(k) clearance for MEDIFLY maggots. Neumora (NMRA) halted KOASTAL Phase 3 and plans 35% layoffs; enGene (ENGN) cuts ~50%. Biogen (BIIB) agreed to buy RayThera for up to $1B.

6 min read

Related tickers

More in Drug Manufacturers - General